KLF1
protein-codingKLF transcription factor 1, the group of Kruppel like factors|Zinc fingers C2H2-type
Gene summary
This gene encodes a hematopoietic-specific transcription factor that induces high-level expression of adult beta-globin and other erythroid genes. The zinc-finger protein binds to the DNA sequence CCACACCCT found in the beta hemoglobin promoter. Heterozygous loss-of-function mutations in this gene result in the dominant In(Lu) blood phenotype. [provided by RefSeq, Oct 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~2.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0013355
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0013355
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0018749
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0013355
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0016672
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0013355
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0013355
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0975829
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Hematologic
Intervention: Hematologic
Rationale: Treatments (including regular RBC transfusions and splenectomy) may be beneficial; Variants associated with a blood group may be important in specific situations (eg, related to transfusion)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KLF1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006563.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 49 | 51 | |||
| missense | 7 | 3 | 117 | 15 | 142 | |
| nonsense | 5 | 4 | 5 | 14 | ||
| start loss | 1 | 1 | ||||
| frameshift | 3 | 3 | 1 | 7 | ||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 15 | 12 | 126 | 64 | 0 | 217 |
Highest pathogenic variant AF is 0.00010567565
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006554.1 | 3 | MANE Select | |
| Ensembl | ENSP00000264834.3 | 3 | MANE Select | |
| Ensembl | ENSP00000546244.1 | 3 | Standard | |
| Ensembl | ENSP00000546244.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Hematopoietic Stem Cell Differentiation
Biological Process
- regulation of transcription, DNA-templated
- regulation of transcription by RNA polymerase II
- erythrocyte differentiation
- positive regulation of transcription, DNA-templated
- positive regulation of transcription by RNA polymerase II
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity
- protein binding
Cellular Component
- nuclear chromatin
- nucleus
- nucleoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000264834
- Coding exons
- 3
- Length
- 2759
- Individuals with no LoFs
- 125626
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 21
- Defined
- 125647
- p
- 0.0000836
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.851 | 171 | 205 | 0.833 | 0.0000104 | 2198 |
| Missense (PolyPhen) | 72 | 93.379 | 0.77105 | 967 | ||
| Synonymous | 0.613 | 89 | 96.7 | 0.921 | 0.00000510 | 795 |
| Loss of Function | 1.26 | 7 | 11.7 | 0.601 | 5.05e-7 | 118 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00012 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00013 | 0.00012 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcription regulator of erythrocyte development that probably serves as a general switch factor during erythropoiesis. Is a dual regulator of fetal-to-adult globin switching. Binds to the CACCC box in the beta-globin gene promoter and acts as a preferential activator of this gene. Furthermore, it binds to the BCL11A promoter and activates expression of BCL11A, which in turn represses the HBG1 and HBG2 genes. This dual activity ensures that, in most adults, fetal hemoglobin levels are low. Able to activate CD44 and AQP1 promoters. When sumoylated, acts as a transcriptional repressor by promoting interaction with CDH2/MI2beta and also represses megakaryocytic differentiation. {ECO:0000250|UniProtKB:P46099, ECO:0000269|PubMed:25585695}.;
- Disease
- DISEASE: Anemia, congenital dyserythropoietic, 4 (CDAN4) [MIM:613673]: A blood disorder characterized by ineffective erythropoiesis and hemolysis resulting in anemia. Circulating erythroblasts and erythroblasts in the bone marrow show various morphologic abnormalities. Affected individuals with CDA4 also have increased levels of fetal hemoglobin. {ECO:0000269|PubMed:21055716, ECO:0000269|PubMed:25585695}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.134
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.929
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |